Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium gluconate is the sodium salt of gluconic acid, a small molecule compound widely utilized in the pharmaceutical industry primarily as an excipient and occasionally as an active pharmaceutical ingredient (API). As an excipient, it functions as a chelating agent, pH regulator, and stabilizer, helping to maintain the integrity and bioavailability of active ingredients in various formulations. When employed as an API, it serves as a physiological electrolyte agent in large-volume parenteral applications and electrolyte replacement solutions. It is particularly valued for its ability to form stable, water-soluble complexes with divalent and trivalent metal ions, which prevents precipitation and enhances the absorption of minerals like calcium and iron.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium gluconate.